Results 181 to 190 of about 33,626 (230)

Differential cognitive enhancer effects of acetylcholinesterase inhibitors and memantine on age-related deficits in vigilance and sustained attention: a preclinical validation study. [PDF]

Behav Brain Funct
Bali ZK, Bruszt N, Göntér K, Hernádi I.   +3 more
europepmc   +1 more source

The role of genetic polymorphisms on drug response in Alzheimer's disease: a systematic review. [PDF]

BMC Med Genomics
Climacosa FMM, Ornos EDB, Gapaz NCLL, Guantia MGR, Cruz JMC, Manalo RVM, Yu ML, Qureshi AP, Carampel AC, Asis JLB, Reyes JCB, Dacasin AB, Anlacan VMM.   +12 more
europepmc   +1 more source

Clinical effect of donepezil hydrochloride in the treatment of Parkinson's disease patients: a meta-analysis. [PDF]

Am J Transl Res
Zhu M, Liang C, Feng W, Qin J, Zhao W.
europepmc   +1 more source

Neuroimaging and molecular mechanism of action of Cang-ai volatile oil in the treatment of vascular cognitive impairment. [PDF]

Front Neurosci
Chen B, Liang B, Li W, Wang L, Wang J, Xiong L, Gao F.   +6 more
europepmc   +1 more source

Novel cinnamic acid-based <i>N</i>-benzyl pyridinium analogs: potent dual cholinesterase inhibitors with neuroprotective properties for Alzheimer's disease. [PDF]

RSC Adv
Esmkhani M, Mahdavi M, Javanshir S, Iraji A.   +3 more
europepmc   +1 more source

Identification of stigmasterol derived AChE inhibitors for Alzheimer's disease using high throughput virtual screening and molecular dynamics simulations. [PDF]

Sci Rep
Rahman MO, Ahmed SS, Alqahtani AS, Rehman MT, Sultana N, Bouhrim M, Ali MA, Lee J.   +7 more
europepmc   +1 more source

Repurposed Arylidene-hydrazinyl-1,3-thiazoles as Multitarget Anti-Alzheimer's Agents via Combined Computational and Experimental Studies. [PDF]

ACS Omega
Drozdowska D, Ratkiewicz A, Wróbel-Tałałaj A, Parzych C, El-Dershaby HA, Abd El-Razik HA, Soliman FSG, El-Wakil MH.   +7 more
europepmc   +1 more source